Surviving an oncologic emergency doesn’t just depend on the patient’s condition, biology, and genetics, but also the capabilities of the treatment center. Daniel Thomas Jones, a recent graduate of the flexible MBA program at the Johns Hopkins Carey Business School, was selected for a 2026 Conquer Cancer Merit Award, for proving that finding in his latest research.
His study, “The oncology capability gap: Failure-to-rescue following high-risk oncologic emergencies in the United States,” reviewed a large national hospitalization database, encompassing approximately 300 million hospitalizations, to understand hospital systems’ ability to save cancer patients after cancer-related, health emergencies occurred and examine how outcomes varied across different hospital environments.
Jones and his colleagues found that patients’ outcomes following an oncologic emergency depended on the nature of their cancer condition and medical complexity as expected, but also on the capabilities of the healthcare setting they were in.
“That distinction is important because many patient-level risk factors cannot be changed—we cannot change the cancer a patient arrived with or many of the biological factors that made them sick,” said Jones. “Healthcare systems, however, can be redesigned.”
The research, according to Jones, wasn’t entirely about patients’ likelihood of developing serious complications or the nature of their cancer, but the healthcare system’s ability to save those patients from high-risk oncologic emergencies. He wanted to know how successful the healthcare system was in recognizing patient deterioration, mobilizing the appropriate resources, and successfully saving the patient in a health emergency.
“That shifts some of the focus from the biology of cancer itself to the design and capabilities of the healthcare system surrounding the patient,” said Jones. “It also raises a larger question that has become central to my research: Can we use the enormous amount of healthcare data already being generated to identify patients at risk before deterioration becomes clinically obvious?”
His thinking was that if differences in patient outcomes are related to factors like access to oncology expertise, critical care resources, recognition of deterioration, or institutional capabilities, then those areas should be further scrutinized and targeted for innovation.
Using healthcare data to predict and prevent emergencies
This kind of research, according to Jones, has the ability to eventually predict and prevent health disasters among patients, using signals identified across millions of health encounters, which could be translated into predictive tools that live within the electronic health record.
While getting his MBA at Carey, Jones added specializations in Healthcare Management and AI in Business and received extensive statistical training in health information technology and electronic health records, which helped him advance this particular research and his broader work.
“My statistics and analytics coursework taught me how to think more rigorously about large datasets, signal versus noise, variation, prediction, uncertainty, and how we can extract meaningful information from complex data,” he said.
MBA helps physicians drive healthcare innovation
Healthcare redesign and innovation is a popular interest for MBA candidates at Carey. Jones says his MBA experience provided him the “systems-level perspective,” that he didn’t know he needed as a medical professional and a researcher.
“Clinical training teaches you how to make the best possible decision for the patient in front of you, but business training teaches you to step back and ask why the system produces the outcomes it does across thousands or millions of patients, where the inefficiencies and failure points are, and how that system might be redesigned,” said Jones. “Healthcare innovation requires both perspectives.”
“If physicians are going to participate meaningfully in solving some of healthcare's largest problems, we need to understand finance, operations, strategy, leadership, technology, analytics, and how healthcare organizations actually function,” he said. “What I did not fully appreciate before earning my MBA was how much that education would also influence the questions I ask scientifically.”
Jones notes that as a physician, you see and experience many of healthcare’s largest pain points like inefficiencies, unnecessary administrative complexity, limitations in technology, and patient frustrations.
“Clinical experience gives physicians a unique vantage point from which to identify those problems, but identifying a problem and knowing how to solve it at scale are very different skills,” he said. “That is one of the most important things Carey taught me.”
Applying business, medicine, and analytics to the future of oncology
Jones is currently an internal medicine resident physician at MountainView Hospital in Las Vegas and pursuing an MPH at the Harvard T.H. Chan School of Public Health. He plans to practice Hematology-Oncology, with a particular interest in cancer drug development and early-phase therapeutics.
His broad research continues to focus on modern computing power, large healthcare databases, and increasingly sophisticated statistical methods to identify clinical signals and patterns that can’t be detected across individual patients or hospitals in isolation. That’s something his MBA skills continue to help him master beyond graduation.
“Medicine, statistics, computing, AI, and healthcare management become especially powerful when brought together,” he says.
